The US House Committee on Appropriation approved a $3.212 billion budget for the 2021 fiscal year. Part of the funding bill also gives the Food and Drug Administration authority to recall unsafe prescription and over-the-counter drugs. The proposed budget also includes a $31 million addition in response to the COVID-19 pandemic to help support the agency in reviewing new therapies and potentially vaccines. The bill will now move on for approval from the House of Representatives.
Read more here.